JNJ vs HCA
By Alex · Tickerpine
Johnson & Johnson vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | HCA |
|---|---|---|
| Price | $271.22 | $435.61 |
| Market cap | $653.61B | $94.31B |
| P/E ratio | 31.5 | 14.6 |
| ROE | 25.74% | — |
| Profit margin | 21.48% | 8.77% |
| Revenue growth | 6.60% | 8.70% |
| Dividend yield | 1.98% | 0.72% |
| Beta | 0.23 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs HCA in plain English
- JNJ is the bigger company — about 6.9× the market cap of HCA.
- HCA is cheaper on earnings (P/E 14.6 vs 31.5).
- HCA is growing revenue faster (9% vs 7%).
- JNJ has the higher dividend yield (1.98% vs 0.72%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.